We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
International Flavors (IFF) Reports Q2 Earnings: What Key Metrics Have to Say
Read MoreHide Full Article
For the quarter ended June 2023, International Flavors (IFF - Free Report) reported revenue of $2.93 billion, down 11.4% over the same period last year. EPS came in at $0.86, compared to $1.54 in the year-ago quarter.
The reported revenue represents a surprise of -5.72% over the Zacks Consensus Estimate of $3.11 billion. With the consensus EPS estimate being $1.10, the EPS surprise was -21.82%.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how International Flavors performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
Net Sales- Nourish: $1.56 billion versus $1.74 billion estimated by four analysts on average. Compared to the year-ago quarter, this number represents a -14% change.
Net sales- Scent: $592 million versus the four-analyst average estimate of $594.94 million. The reported number represents a year-over-year change of +2.1%.
Net Sales- Pharma Solutions: $251 million compared to the $250.74 million average estimate based on four analysts. The reported number represents a change of +2.9% year over year.
Net Sales- Health & Biosciences: $522 million versus $540.96 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a -21.5% change.
Adjusted Operating EBITDA- Nourish: $181 million versus the four-analyst average estimate of $285.21 million.
Adjusted Operating EBITDA- Pharma Solutions: $67 million versus $57.11 million estimated by four analysts on average.
Adjusted Operating EBITDA- Scent: $117 million compared to the $104.45 million average estimate based on four analysts.
Adjusted Operating EBITDA- Health & Biosciences: $145 million versus $139.56 million estimated by four analysts on average.
Shares of International Flavors have returned +2.4% over the past month versus the Zacks S&P 500 composite's +0.6% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
International Flavors (IFF) Reports Q2 Earnings: What Key Metrics Have to Say
For the quarter ended June 2023, International Flavors (IFF - Free Report) reported revenue of $2.93 billion, down 11.4% over the same period last year. EPS came in at $0.86, compared to $1.54 in the year-ago quarter.
The reported revenue represents a surprise of -5.72% over the Zacks Consensus Estimate of $3.11 billion. With the consensus EPS estimate being $1.10, the EPS surprise was -21.82%.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how International Flavors performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Net Sales- Nourish: $1.56 billion versus $1.74 billion estimated by four analysts on average. Compared to the year-ago quarter, this number represents a -14% change.
- Net sales- Scent: $592 million versus the four-analyst average estimate of $594.94 million. The reported number represents a year-over-year change of +2.1%.
- Net Sales- Pharma Solutions: $251 million compared to the $250.74 million average estimate based on four analysts. The reported number represents a change of +2.9% year over year.
- Net Sales- Health & Biosciences: $522 million versus $540.96 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a -21.5% change.
- Adjusted Operating EBITDA- Nourish: $181 million versus the four-analyst average estimate of $285.21 million.
- Adjusted Operating EBITDA- Pharma Solutions: $67 million versus $57.11 million estimated by four analysts on average.
- Adjusted Operating EBITDA- Scent: $117 million compared to the $104.45 million average estimate based on four analysts.
- Adjusted Operating EBITDA- Health & Biosciences: $145 million versus $139.56 million estimated by four analysts on average.
View all Key Company Metrics for International Flavors here>>>Shares of International Flavors have returned +2.4% over the past month versus the Zacks S&P 500 composite's +0.6% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.